
UK initiates review of clinical trials after decreases in recruitment, number of studies
The UK’s once-strong clinical research landscape has been shrinking over the past five years, prompting the government to open an investigation into what can be done to salvage and rebuild.
The UK has appointed former health minister James O’Shaughnessy to review the state of commercial clinical trials in the country and make recommendations based on his findings. The recommendations are expected to be published this spring and will include how to improve and increase clinical trials in 2023 and future years.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.